A potent and selective TNKS2 inhibitor for tumor-selective WNT suppression
Zimmerman, J.; Malone, B.; Finkin-Groner, E.; Sun, S.; Liang, R.; Foronda, M.; Schatoff, E.; Granowsky, E.; Goswami, S.; Katti, A.; Leach, B.; Alcorn, H.; Tammela, T.; Fukase, Y.; Khan, T.; Huggins, D.; Ginn, J.; Liverton, N.; Hite, R.; Dow, L.
Show abstract
Hyperactive WNT signaling is a potent cancer driver, but clinical translation of WNT inhibitors has been hampered by on-target toxicities. WNT signaling can be constrained through inhibition of the PARP family enzymes Tankyrase 1 (TNKS1) and Tankyrase 2 (TNKS2), however, existing TNKS inhibitors suppress WNT signaling in both tumor and healthy tissues. In this study, we show that the loss of chromosome 8p that occurs in approximately half of advanced epithelial malignancies, creates a collateral vulnerability that enables tumor-selective inhibition of Tankyrase activity. 8p loss depletes expression of TNKS1 and creates a tumor-specific dependency on the functionally redundant TNKS2 protein. Through structure-guided drug design, we identify a first-in-class TNKS2-selective inhibitor that can drive selective WNT inhibition in TNKS1-deficient oncogenic cell and organoid models. This work demonstrates a targetable vulnerability in multiple cancer types, providing a new approach to potent and selective WNT-targeted therapies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. 95%
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 95%
- Rapidly induced drug adaptation mediates escape from BRAF inhibition in single melanoma cells 95%
Similar papers in this journal
- MLL1 regulates cytokine-driven cell migration and metastasis 95%
- Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling 95%
- Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions 95%
Similar papers in this journal
- SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status 95%
- TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway 95%
- Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.